Medicure Inc. (CVE:MPH – Get Free Report) shares hit a new 52-week low on Monday . The stock traded as low as C$0.82 and last traded at C$0.82, with a volume of 1000 shares. The stock had previously closed at C$0.87.
Medicure Stock Up 1.2 %
The firm has a market capitalization of C$8.67 million, a P/E ratio of -3.32 and a beta of 0.90. The company has a debt-to-equity ratio of 2.06, a quick ratio of 1.29 and a current ratio of 1.87. The stock has a 50 day moving average of C$0.92 and a 200-day moving average of C$0.99.
About Medicure
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Recommended Stories
- Five stocks we like better than Medicure
- Ride Out The Recession With These Dividend Kings
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- How to Invest in Small Cap Stocks
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- What Are Earnings Reports?
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
